Member Info for Saint68

Please don’t go on. This is a BB for EUA not a political sounding board.

He’s now been renamed Aldemoron on the Avacta board 😂😂

DB3 - you posted similar about your contacts in March so I’m calling bull..it I’m afraid.

A quick summary of JHFH’s essay for the green boxes. You’re all twats 👍

CBR has the potential to be the jewel in the crown here so wouldn’t want to give too much of that away at such an early stage in it’s development.

I would have if I knew who posted - binned the twat so no idea what he’s saying now.

Because he’s a coño completo.

Saw my name in the left hand column but poster was blocked. Assumed it was Aldebaran so unblocked him.

You’re a hindsight poster - failing to note the key word in my post “currently”. You reply over 2 hours later - clown. Back in the bin for good.

I know but he’s been doing it on this board - not acceptable.

We’re flat here and Avacta currently down 5% - ramping not turned out as expected. Bin for another twat. I’ll be sure to tell the board there how you love seeing people lose money. I’m sure it’ll go down well.

PurpleKenny - you do know that Vlad hasn’t bought for himself don’t you ?

Cabal strikes again - seems the loophole is never ending.

No offense but you’ve posted more than anyone about Avacta today. I replied once to Alder then went out for the day. I came home and there were multiple posts by you. The companies are not really comparable because they’re in different stages of development but to state they have a death spiral so must be not as good is ridiculous. That’ll be my final post on it.

*dosing - costing.

JHFH - as I said, until you know more about the Avacta pipeline I’d refrain from commenting or you’re going to look stupid. Let’s take a look at some of your statements :

“ But their pipeline in comparison to Hemo is pants, they want to make chemo better targeted to reduce toxicity..” - what about the use of precision in non oncology diseases ? - seems AI hasn’t taken that into consideration - probably using the same one that told you our 3 scientists were dosing 100k per month.

“ How much debt does AVCT have? Now hemo?” - CLN is now in the process of getting sorted so no longer a drag on the company. Avacta funded until end of Q1 2026. Hemo funded until …. Who knows but no more than 2 months.

“ And if you consider the potential of CBR? AvCT have nothing comparable. What AVCT have over Hemo?” - we don’t know enough about CBR to know the potential and it could be some time before it enters trials. Avacta have the potential to take a huge market share in multiple forms of cancer and are years into their phase 1a/b. Taken so long as they’ve been unable to find an MTD due to the incredible safety.

That’s enough and this is the Hemo board.

JHFH - I did bring it up with him first but my post what’s been deleted along with his original post. Guess you missed my reply to him.

Aldebaran - you’re a hypocrite and are always trying to shoot people down on the Avacta board for anything negative. You’re in no position to criticise here.

JHFH - the CLN is being dealt with so not really an issue. Also they haven’t diluted nearly 50% this year so please stick to Hemo and things you have a good grasp of.

Surprised you knew about that - with only having joined 2 dats ago. Binned - just saying.

My bad - scrolled down to the historical figures and missed the statement at the top. Cheers

Here's the data that was posted on Friday

10 July 2024 ... 0.78% shorted ... 359,042,104 shares in issue ... 2,800,528 shares shorted

24 July 2025 ... 0.67% shorted ... 404,548,875 shares in issue ... 2,710,477 shares shorted

Short reduced by 90,051 shares